ArticleAdvances in therapy2023

Biomarker Testing for Actionable Alterations in NSCLC-Perspectives from US-Based Academic and Community Oncologists: A Podcast.

Wade T Iams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.